Biomerics, a medical device contract manufacturer, has announced it is doubling its manufacturing footprint in the La Zeta Free Trade Zone in Cartago, Costa Rica. Biomerics held a joint groundbreaking ceremony with La Zeta and CINDE.
The expansion is via a new greenfield plant adjacent to Biomerics current operations and includes extrusion, injection moulding, micro metal processing, and cleanroom assembly process.
The expansion is via a new greenfield plant adjacent to Biomerics current operations
The new facility construction totalling 110,000 sqft will reflect Biomerics vertically integrated, full-service business model and will include engineering labs, quality inspection labs, controlled environment manufacturing, office space, class 7 cleanrooms, packaging, and warehouse facilities.
Biomerics currently employs 175 people at its 50,000 sqft facility focused on extrusion, laser processing, high volume assembly, and packaging. The expansion is in support of active transfer programs with strategic customers and is expected to double its number of Costa Rican employees over the next three years.
"This expansion is in line with our vision to be the leading interventional contract manufacturer," said Travis Sessions, Biomerics CEO. "Customers have requested that we build a vertically integrated operation in Costa Rica to provide cost-effective high volume manufacturing for the interventional market."
"We are excited for the value that this expansion brings to our existing customer base in Costa Rica and interventional OEM partners around the globe," explained Chris Richardson, Biomerics Director of Sales and Marketing. "The thriving medical device ecosystem in Costa Rica aligns well with Biomerics' culture and innovative core."
Construction is expected to be completed by Q4 2021 and will be celebrated with an open house.
